Issue navigation
Volume 17, Issue 6, 1 June 2011
Original Articles
Measurement of disease activity in ulcerative colitis:Interobserver agreement and predictors of severity
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1257–1264, https://doi.org/10.1002/ibd.21480
Clinical course of Crohn's disease following treatment of lymphoma
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1265–1269, https://doi.org/10.1002/ibd.21487
Socioeconomic and psychological factors associated with nonadherence to treatment in inflammatory bowel disease patients:Results of the ISSEO survey
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1270–1276, https://doi.org/10.1002/ibd.21482
Effects of social support on the clinical course of Crohn's disease
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1277–1286, https://doi.org/10.1002/ibd.21481
Diagnosis and management of afferent limb syndrome in patients with ileal pouch-anal anastomosis
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1287–1290, https://doi.org/10.1002/ibd.21503
Identification of a novel autoantigen in inflammatory bowel disease by protein microarray
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1291–1300, https://doi.org/10.1002/ibd.21508
Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1301–1307, https://doi.org/10.1002/ibd.21458
Prospective evaluation of the clinical utility of interferon-γ assay in the differential diagnosis of intestinal tuberculosis and Crohn's disease
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1308–1313, https://doi.org/10.1002/ibd.21490
Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1314–1321, https://doi.org/10.1002/ibd.21493
Bile acid malabsorption in inflammatory bowel disease:Assessment by serum markers
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1322–1327, https://doi.org/10.1002/ibd.21502
Individual health discount rate in patients with ulcerative colitis
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1328–1332, https://doi.org/10.1002/ibd.21515
Epidemiologic characteristics of patients with inflammatory bowel disease undergoing colonoscopy
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1333–1337, https://doi.org/10.1002/ibd.21513
Increased risk of vancomycin-resistant enterococcus (VRE) infection among patients hospitalized for inflammatory bowel disease in the United States
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1338–1342, https://doi.org/10.1002/ibd.21519
IRF4 regulates IL-17A promoter activity and controls RORγt-dependent Th17 colitis in vivo
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1343–1358, https://doi.org/10.1002/ibd.21476
NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1359–1372, https://doi.org/10.1002/ibd.21478
Colitis locus on chromosome 2 impacting the severity of early-onset disease in mice deficient in GPX1 and GPX2
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1373–1386, https://doi.org/10.1002/ibd.21479
Genetic association between NLRP3 variants and Crohn's disease does not replicate in a large UK panel
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1387–1391, https://doi.org/10.1002/ibd.21499
Genetic variation in the autophagy gene ULK1 and risk of Crohn's disease
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1392–1397, https://doi.org/10.1002/ibd.21486
Prior Helicobacter pylori infection ameliorates Salmonella typhimurium-induced colitis:Mucosal crosstalk between stomach and distal intestine
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1398–1408, https://doi.org/10.1002/ibd.21489
Intracolonic infusion of fecal supernatants from ulcerative colitis patients triggers altered permeability and inflammation in mice: Role of cathepsin G and protease-activated receptor-4
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1409–1414, https://doi.org/10.1002/ibd.21454
Clinical Reviews
Development of the Crohn's disease digestive damage score, the Lémann score
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1415–1422, https://doi.org/10.1002/ibd.21506
Nonmelanoma skin cancer in inflammatory bowel disease: A review
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1423–1427, https://doi.org/10.1002/ibd.21484
Optimizing thiopurine therapy in inflammatory bowel disease
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1428–1435, https://doi.org/10.1002/ibd.21494
Selected Summaries
MD-2: Another important piece of the puzzle?
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1436–1437, https://doi.org/10.1002/ibd.21485
Letters to the Editors
IL-10RA truncation mutations and semite populations
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Page 1438, https://doi.org/10.1002/ibd.21495
Functional SFTPD gene variants are not associated with susceptibility to inflammatory bowel disease in the German population
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1439–1440, https://doi.org/10.1002/ibd.21500
Novel thiopurine methyltransferase variant TPMT*28 results in a misdiagnosis of TPMT deficiency
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1441–1442, https://doi.org/10.1002/ibd.21505
Mycobacterium marinum infection in the setting of antitumor necrosis factor alpha therapy for Crohn's disease
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1443–1444, https://doi.org/10.1002/ibd.21512
Missense mutation V20A in the tumor necrosis factor receptor superfamily 1A (TNFRSF1A) gene is associated with tumor necrosis factor receptor-associated periodic syndrome (TRAPS) presenting with periodic gastrointestinal symptoms
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1445–1446, https://doi.org/10.1002/ibd.21523
Long-term therapy with sargramostim in a patient with Crohn's disease
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages 1447–1448, https://doi.org/10.1002/ibd.21542
Eruptive benign melanocytic naevi during immunosuppressive therapy in a Crohn's disease patient
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Page E26, https://doi.org/10.1002/ibd.21618
No large ulcer: A predictor of latent cytomegalovirus infection in ulcerative colitis
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Page E27, https://doi.org/10.1002/ibd.21641
Diagnostic pitfalls: Cancerization in IBD versus mantle cell lymphoma presenting with multiple lymphomatous polyposis1
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages E28–E30, https://doi.org/10.1002/ibd.21642
Granulomatous duodenitis mimicking Crohn's disease caused by Capnocytophaga sp.
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages E31–E32, https://doi.org/10.1002/ibd.21645
Residual hydrocephalus after tuberculous meningitis in a patient with biological therapy
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages E33–E34, https://doi.org/10.1002/ibd.21664
Splenic granulomas in a patient with severe Crohn's disease associated with multiple extraintestinal manifestations
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages E35–E37, https://doi.org/10.1002/ibd.21665
Functional polymorphism in IL12B promoter site is associated with ulcerative colitis
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages E38–E40, https://doi.org/10.1002/ibd.21670
Failure of anakinra treatment of pyoderma gangrenosum in an IBD patient and relevance to the PSTPIP1 gene
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages E41–E42, https://doi.org/10.1002/ibd.21684
Early postoperative recurrence of severe crohn's disease, with colonic involvement and associated human cytomegalovirus infection, treated with oral valganciclovir and adalimumab
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages E43–E44, https://doi.org/10.1002/ibd.21685
Meckel's ileitis: Not all regional enteritis is Crohn's disease
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Page E45, https://doi.org/10.1002/ibd.21686
Comparative effectiveness research in inflammatory bowel disease
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages E46–E47, https://doi.org/10.1002/ibd.21693
Abdominal pain due to cholecystitis as first sign of septic salmonellosis in a patient with Crohn's disease on infliximab
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages E48–E49, https://doi.org/10.1002/ibd.21694
Interleukin-18 upregulation is associated with the use of steroids in patients with ulcerative colitis
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages E50–E51, https://doi.org/10.1002/ibd.21700
Terminal ileitis in a renal transplanted patient: Could it be infectious ileitis, crohn's disease, or pharmacological toxicity?
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages E52–E53, https://doi.org/10.1002/ibd.21701
Pneumoperitoneum in a patient with ulcerative colitis after sigmoidoscopy: Is this always an indication for surgery?
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages E54–E56, https://doi.org/10.1002/ibd.21704
Adenocarcinoma arising from ileoanal J-pouch mucosa: An announced event?
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages E57–E58, https://doi.org/10.1002/ibd.21711
Circulating OPG levels are reduced following infliximab treatment and correlate with CRP levels: Is serum OPG a potential marker of IBD disease activity?
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages E59–E60, https://doi.org/10.1002/ibd.21714
Severe muscular weakness as an isolated symptom of azathioprine hypersensitivity
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Page E61, https://doi.org/10.1002/ibd.21715
Natalizumab to kill two birds with one stone: A case of celiac disease and multiple sclerosis
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages E62–E63, https://doi.org/10.1002/ibd.21716
Rare cause of fever in a patient with ulcerative colitis
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages E64–E65, https://doi.org/10.1002/ibd.21721
Erratum
Erratum
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Page 1449, https://doi.org/10.1002/ibd.21743
